BackTable / Tumor Board / Contributor

Dr. Amanda Nizam
Oncologist
Dr. Amanda Nizam is a genitourinary medical oncologist practicing at Clevelant Clinic in Cleveland, Ohio.
Listen to Dr. Amanda Nizam on the BackTable Podcast
The BackTable Podcast is a knowledge resource by physicians for physicians. Learn from the experiences and expertise of Dr. Amanda Nizam and get practical advice on how to build your practice by listening to the BackTable Podcast.
Stay Up To Date
Follow:
Subscribe:
Sign Up:
About Dr. Amanda Nizam
Dr. Amanda Nizam is a genitourinary medical oncologist and Associate Staff in the Department of Hematology and Medical Oncology at The Cleveland Clinic Taussig Cancer Institute, where she specializes in the diagnosis and treatment of patients with bladder/upper urinary tract, renal, and prostate cancers.
Dr. Nizam's research interests include treatment-related toxicity in patients receiving novel therapeutics for genitourinary cancers and the development of clinical trials for bladder/urinary tract cancers. Her long-term goal is to become a clinical investigator specialized in the development of clinical trials for bladder/urinary tract malignancies and in the risk identification and mitigation of treatment-related toxicity.
In addition to her clinical and research interests, Dr. Nizam is engaged in national legislative advocacy efforts aimed at advancing biomedical research and improving oncologic care in the U.S.
Learn more by visiting Dr. Amanda Nizam's practice:
Podcasts Featuring Dr. Amanda Nizam
Articles Featuring Dr. Amanda Nizam
Get in touch!
We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.
Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.















